Search for
Sort by 
Page
Showing 1 - 25 of 973 documents.
Interventional/Surgery
7 COMMENTS - Nov 6, 2009 18:22 EST
Interventional cardiologist, Dr Donald Baim, chief medical and scientific officer at Boston Scientific, has died.
Acute Coronary Syndromes
Nov 6, 2009 17:15 EST
The latest recommendations for the treatment of ST-elevation MI issued by American cardiology associations and the European Society of Cardiology are compared and contrasted in a new paper.
Interventional/Surgery
7 COMMENTS - Nov 4, 2009 17:00 EST
A 2203-patient randomized trial of off-pump vs on-pump CABG surgery found no differences in neuropsychological outcomes and worse overall outcomes for the off-pump group at one-year follow-up.
Interventional/Surgery
Nov 4, 2009 15:30 EST
The imaging study was the first to show that stenting a non-flow-limiting stenosis of an SVG may help slow or halt the accelerated atherosclerosis that takes place in these vessels. An accompanying editorial cautions that the study does little more than "infer a trend toward anatomic benefit."
heartbriefs
Nov 4, 2009 13:15 EST
In keeping with all the other evidence showing no effects of homocysteine-lowering with B vitamins, the FAVORIT study now confirms that this lack of benefit is also seen in renal-transplant recipients.
MediaPulse
13 COMMENTS - Nov 3, 2009 15:15 EST
Dr David Gossman has filed a lawsuit claiming that he was fired for complaining about ties between the hospital and some of its senior staff with the medical device company Medtronic.
Interventional/Surgery
5 COMMENTS - Nov 3, 2009 14:30 EST
A US update on the perioperative use of beta blockers for noncardiac surgery is, says the lead author, "similar" to recent European guidance on this issue.
Interventional/Surgery
Oct 30, 2009 16:45 EDT
Researchers in Ottawa find that the longevity of porcine replacement heart valves may depend partly on whether the blood type of the patient matches the blood type of the valve's "original owner."
Interventional/Surgery
1 COMMENT - Oct 28, 2009 16:45 EDT
Only 101 of 1169 post-bypass-surgery patients eligible for an ICD got one over a 13-year period in Nova Scotia.
Acute Coronary Syndromes
1 COMMENT - Oct 28, 2009 14:30 EDT
After a median follow-up of 12 years, MI rates were essentially the same among those treated with surgery and those who received conventional care for weight loss.
Acute Coronary Syndromes
4 COMMENTS - Oct 27, 2009 14:30 EDT
Women and men have the same rates of chest pain and other classic symptoms during ACS, although women are more likely to experience some other symptoms such as jaw and neck pain.
Interventional/Surgery
1 COMMENT - Oct 27, 2009 13:00 EDT
Speaking at the 30th anniversary of the GISE Congress, Palmaz said he'd never believed drug elution was the way forward for stents and outlined his theories for why coatings of any kind disrupt the healing properties of metallic coronary stents.
Interventional/Surgery
2 COMMENTS - Oct 27, 2009 12:15 EDT
Administration of blood products to stable patients post-cardiac surgery increases their risk of death, renal failure, and sepsis, according to new research.
Interventional/Surgery
4 COMMENTS - Oct 26, 2009 13:00 EDT
A new analysis of national registry data suggests that the superior outcomes of NSTEMI patients in hospitals with open-heart-surgery capabilities vs those without it are due to their size, procedure volume, and adherence to medication guidelines.
Brain/Kidney/Peripheral
Oct 21, 2009 13:00 EDT
Intravenously administered iloprost, a prostacyclin analog, may help prevent contrast-induced nephropathy in patients with renal dysfunction undergoing coronary procedures, a new pilot study suggests.
Interventional/Surgery
4 COMMENTS - Oct 20, 2009 13:45 EDT
Warfarin use is rising in both older and younger patients. How much does the anticoagulant contribute to the risk of traumatic injuries?
Interventional/Surgery
Oct 20, 2009 11:30 EDT
There are significant cost savings with statin therapy before abdominal aortic aneurysm repair, and the complication rate is less than half that of patients who do not receive preop statins.
Thrombosis Risk
3 COMMENTS - Oct 19, 2009 12:45 EDT
New results from an Italian registry reopen the question of how long drug-eluting stent recipients should stay on a dual antiplatelet regimen to prevent late thrombosis.
Imaging
14 COMMENTS - Oct 16, 2009 12:45 EDT
In those presenting to the ER with chest pain, a prior zero calcium score cannot completely rule out a coronary obstruction, a new analysis of the MESA study has shown. This is likely due to the presence of soft plaques not detected by calcium screening, the researchers say.
Interventional/Surgery
Oct 15, 2009 14:15 EDT
The OVER study of abdominal aortic aneurysm shows that endovascular grafting has a lower mortality rate at 30 days than traditional open surgery.
Interventional/Surgery
2 COMMENTS - Oct 14, 2009 14:45 EDT
The group argues that the data are substantive enough for left main PCI to be a class IIb indication or even a class IIa indication in selected patients without coexisting multivessel disease. In contrast, the current ACC/AHA guidelines make left main PCI a class III indication unless patients are ineligible for CABG surgery.
Interventional/Surgery
5 COMMENTS - Oct 14, 2009 11:00 EDT
Scripps Health has announced that it is now offering patients undergoing elective stenting a test for the gene variants associated with an inability to convert clopidogrel to its active metabolite so that antiplatelet therapy can be individualized.
Features
4 COMMENTS - Oct 8, 2009 13:15 EDT
Under the some-say-misguided term "metabolic" surgery, gastric bypass is now being used in some instances to treat diabetics who are not considered morbidly obese. Experts say the mostly circumstantial evidence on this is intriguing, but prospective data are desperately needed in this group of patients.
Acute Coronary Syndromes
Oct 6, 2009 16:00 EDT
Even among patients with documented ischemic heart disease, an intensive program of education and counseling about the importance of seeking treatment quickly does not lead to reductions in prehospital delays or increased ambulance use among those experiencing the signs and symptoms of an ACS, a new study shows.
Interventional/Surgery
1 COMMENT - Oct 5, 2009 16:45 EDT
The trial, rumored to cost more than $100 million, is a first for collaboration: eight drug and device companies are backing the trial, along with the FDA. The study is powered to detect a difference in stent thrombosis and major adverse events between patients taking 12 or 30 months of aspirin plus clopidogrel or prasugrel.

Search for
Sort by 
Page
Showing 1 - 25 of 973 documents.
button

Featured programs
Poll
Will the best stents of the future have some kind of polymer coating?
See: Stent pioneer Julio Palmaz urges DES makers to "learn from mistakes of the past"
Yes
No

Inside: Interventional/Surgery